Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibody-drug conjugates
Biotech
Daiichi stops internal development of next-wave ADC
Daiichi management argued that the decision was not about the new mPBD platform but instead stems from “a business and portfolio perspective.”
Angus Liu
Feb 2, 2026 10:55am
Fierce Pharma
Halozyme catches M&A wave to snap up Surf Bio
Jan 28, 2026 2:06pm
Fortitude has faith glue degraders can beat ADC resistance
Jan 26, 2026 10:47am
AbbVie pens $5.6B pact with RemeGen to join PD-1xVEGF race
Jan 12, 2026 11:00am
InduPro nabs 2nd Big Pharma deal with $950M Lilly pact
Jan 7, 2026 3:52pm
Ipsen's ADC push leads to $1B deal for preclinical Simcere drug
Dec 22, 2025 7:15am
